Upload Avatar (500 x 500)
Yi Yao
Medical School
Wuhan University
Hubei
Language: English, Chinese
Tumor Microenvironment
Precision Therapy
Dna Damage
Repair Mechanisms
Cancer Therapy
Oncology
Cellular Response
Molecular Targeting
Therapeutic Strategies
Clinical Outcomes
Areas of Focus
- Tumor microenvironment and precision therapy
- DNA damage repair and antitumor therapy
Work Experience
- 2008.07-2008.11: Resident Physician, Cancer Center, Renmin Hospital, Wuhan University
- 2008.12-2012.11: Attending Physician, Cancer Center, Renmin Hospital, Wuhan University
- 2012.12-present: Associate Chief Physician, Cancer Center, Renmin Hospital, Wuhan University
- 2014.07-2015.09: Visiting Scholar, Heidelberg University Hospital, Germany
- 2016.08-2016.09: Visiting Scholar, MD Anderson Cancer Center, USA
- 2022.09-present: Director, Department of Oncology, Renmin Hospital, Wuhan University
Academic Background & Achievements
- 1998-2003: Bachelor of Clinical Medicine, Wuhan University
- 2003-2008: PhD in Internal Medicine, Wuhan University
- Received funding from the National Natural Science Foundation of China and other provincial and educational grants
Publications
- FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis, Y Yao et al., 2023
- Turbulence of Glutamine Metabolism in Pan-cancer Prognosis and Immune Microenvironment, Y Yao et al., 2022
- Irradiation enhances the malignancy-promoting behaviors of cancer-associated fibroblasts, Y Yao et al., 2022
- Identification and validation for biological characteristic and prognosis of tumor microenvironment subtypes in patients with lung adenocarcinoma, Y Yao et al., 2022
- Comprehensive analysis identifies and validates the tumor microenvironment subtypes to predict anti-tumor therapies efficacy in Hepatocellular carcinoma, Y Yao et al., 2022
- A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma, Y Yao et al., 2022
- Tumor-educated platelets facilitate thrombus formation through migration, Y Yao et al., 2022
- Predict radiation pneumonitis using a genome-scale flux analysis on RNA-seq derived from peripheral blood, Y Yao et al., 2021
- Individualized model for predicting COVID-19 deterioration in patients with cancer: A multicenter retrospective study, Y Yao et al., 2021
- Risk factors for distant metastasis of patients with primary triple-negative breast cancer, Y Yao et al., 2019
- Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study, Y Yao et al., 2019
- Radiotherapy after surgery has significant survival benefits for patients with triple negative breast cancer, Y Yao et al., 2019
- Detecting EGFR Mutations and ALK/ROS1 Rearrangements in Non-Small Cell Lung Cancer Using Malignant Pleural Effusion Samples, Y Yao et al., 2019
- Naringenin ameliorates radiation-induced lung injury by lowering IL-1β level, Y Yao et al., 2018
- Mesenchymal stem cells: a double-edged sword in radiation-induced lung injury, Y Yao et al., 2018
Awards
- Hubei Province Natural Science Excellent Academic Paper, Second Prize
- Chinese Medical Association Medical Education Branch, Teaching Research Achievement, Second Prize
- Huangshi City Science and Technology Progress, Second Prize
- Wuhan University Renmin Hospital 'Medical Elite', 'People's Anti-Epidemic Model'
